-
1 Comment
Asahi Intecc Co., Ltd is currently in a long term downtrend where the price is trading 13.1% below its 200 day moving average.
From a valuation standpoint, the stock is 78.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 14.9.
Asahi Intecc Co., Ltd's total revenue sank by 10.0% to $14B since the same quarter in the previous year.
Its net income has dropped by 28.4% to $2B since the same quarter in the previous year.
Based on the above factors, Asahi Intecc Co., Ltd gets an overall score of 1/5.
ISIN | JP3110650003 |
---|---|
Exchange | TSE |
CurrencyCode | JPY |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
Market Cap | 597B |
---|---|
Beta | 0.65 |
Target Price | 3345.3333 |
Dividend Yield | 2.1% |
PE Ratio | 32.7 |
Asahi Intecc Co., Ltd. engages in the development, manufacture, and sale of medical devices in Japan, the United States, Europe, China, and internationally. It operates through Medical Business and Device Business segments. The company provides percutaneous transluminal coronary angioplasty (PTCA) guide wires, PTCA guiding catheters, PTCA balloon catheters, and penetration catheters for cardiology; peripheral guide wires, IVR guide wires, micro catheters, and cerebrovascular system guide wires for peripheral vascular, abdominal vascular, and cerebrovascular systems; and guide wires and catheters for angiography. In addition, it offers OEM/ODM services for medical devices; and medical and industrial components, such as element wires, stranded conductors, coils, tubes, terminal processing products, and other products. Further, the company develops, manufactures, and sells ultra-fine stainless steel wire ropes, terminal processed products, etc. The company was formerly known as Asahi Mini Rope Sales Co., Ltd. and changed its name to Asahi Intecc Co., Ltd. in July 1988. Asahi Intecc Co., Ltd. was incorporated in 1976 and is headquartered in Aichi, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 7747.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025